LSCDS #ScienceNews and #Innovation

This week in #ScienceNews and #Innovation: Mice model of psychotic illness could offer new insights into mental illness A team at Washington University School of Medicine have constructed an approach to objectively identify hallucination like events using a computer generated game paradigm that can be used both in humans and mice alike. The researchers predict [...]

By |2021-04-11T21:07:53-04:00April 11th, 2021|ScienceNews&Innovation|0 Comments

LSCDS #ScienceNews and #Innovation

This week in #ScienceNews and #Innovation, the Clevers Laboratory at the University Medical Center Utrecht in the Netherlands discovered a way to grow organoids of tear glands that ‘cry’ tear-like fluid. (Image Credit: Yorick Post/Hubrecht Institute) And with the current rise of artificial intelligence in the life sciences sector, Insitro Inc. secured $400 million of [...]

By |2021-03-18T13:38:58-04:00March 18th, 2021|ScienceNews&Innovation|0 Comments

LSCDS #ScienceNews and #Innovation

This week in #ScienceNews and #Innovation, Canon Medical expands reach of its MRI artificial intelligence programs. How ecstasy and psilocybin are shaking up psychiatry: Regulators will soon grapple with how to safely administer powerful psychedelics for treating depression and post-traumatic stress disorder. (Image Credit: Gizem Vural) Major nutrition study aims to learn which diet best [...]

By |2021-02-04T22:41:07-05:00February 4th, 2021|ScienceNews&Innovation|0 Comments

LSCDS #ScienceNews and #Innovation

This week in #ScienceNews and #Innovation: How long does immunity against SARS CoV-2 last? Scientists at Rockefeller University say that individuals who recover from COVID-19, seem to be protected for at least six months and may be even longer. Read more In #Technology a team from Columbia Engineering’s Creative Machines Lab showcased a pair robots, [...]

By |2021-01-28T21:21:59-05:00January 28th, 2021|ScienceNews&Innovation|0 Comments

LSCDS #ScienceNews and #Innovation

This week in #ScienceNews and #Innovation, a study in Stem Cell Reports shows promising evidence for the use of stem cell replacement therapies in treating blindness caused by macular degeneration. (Image Credit: Xinyi Su) And, as countries launch their vaccination programs, one question keeps reappearing: does the length of time between COVID-19 doses really matter? [...]

By |2021-01-21T10:36:31-05:00January 21st, 2021|ScienceNews&Innovation|0 Comments

LSCDS #ScienceNews and #Innovation

This week in #ScienceNews and #Innovation, Covid-19 vaccination begins after the FDA granted emergency-use authorization for both the Pfizer-BioNTech vaccine and the Moderna vaccine. Stay informed on new Covid-19 research updates here. And with the current pandemic at hand, the integration of virtual platforms into the healthcare industry has led to the rise of a [...]

By |2021-01-07T13:49:20-05:00January 7th, 2021|ScienceNews&Innovation|0 Comments

LSCDS #ScienceNews and #Innovation

This week in #ScienceNews and #Innovation, Moderna and the Pfizer/BioNTech collaboration race to the market with their Covid-19 vaccines. With Moderna announcing an efficacy of 94.1% and Pfizer/BioNTech reporting a 95% efficacy, both companies are aiming to release 70 million combined doses by the end of the year. And with the ongoing pandemic in mind, [...]

By |2020-12-01T21:55:02-05:00December 1st, 2020|ScienceNews&Innovation|0 Comments

LSCDS #ScienceNews and #Innovation

This week in #ScienceNews and #Innovation, the rush to deploy the Oxford-AstraZeneca vaccine has scientists worried about the overall presumptions about efficacy with Phase III trials. (Image Credit: Dogukan Keskinkilic/Anadolu Agency/Getty) GE healthcare has developed a new chest X-ray AI to reduce complications from poor ventilator tube placement. (Image Credit: Getty)

By |2020-11-24T18:23:11-05:00November 24th, 2020|ScienceNews&Innovation|0 Comments

LSCDS #ScienceNews and #Innovation

This week in #ScienceNews and #Innovation, researchers from Duke University have developed lab-grown mini-lungs that allow them to observe coronavirus infection in real-time (Image Credit: Sanford Burnham Preby’s Medical Discovery Institute) Next up, a clinical trial for a Covid-19 antibody released by Eli Lilly has been cancelled due to safety risks and a low likelihood [...]

By |2020-11-16T14:18:59-05:00November 16th, 2020|ScienceNews&Innovation|0 Comments

LSCDS #ScienceNews and #Innovation

This week in #ScienceNews and #Innovation, Pfizer and BioNTech are the talk of the town. The companies announced Monday that their mRNA vaccine was more than 90% effective at preventing disease from COVID-19 infection, based on early analysis of their phase 3 clinical trial. Though the data is not yet complete, nor peer-reviewed, and many [...]

By |2020-11-12T16:56:24-05:00November 12th, 2020|ScienceNews&Innovation|0 Comments
Go to Top